To assess the extent of promoter methylation in the hub genes COL1A1, COL1A2, COL3A1, and FN1 within clinical GC samples, we enrolled a total of 39 individuals diagnosed with GC, along with 39 healthy individuals from the Pakistani population. This evidence concerns the gene COL3A1 and gastric cancer.